Irit Arbel - Net Worth and Insider Trading
Irit Arbel Net Worth
The estimated net worth of Irit Arbel is at least $12,259 dollars as of 2024-11-13. Irit Arbel is the Director of Brainstorm Cell Therapeutics Inc and owns about 10,389 shares of Brainstorm Cell Therapeutics Inc (BCLI) stock worth over $12,259. Details can be seen in Irit Arbel's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Irit Arbel has not made any transactions after 2019-08-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Irit Arbel
Irit Arbel Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Irit Arbel owns 3 companies in total, including Brainstorm Cell Therapeutics Inc (BCLI) , Online Disruptive Technologies Inc (ONDR) , and Pluri Inc (PLUR) .
Click here to see the complete history of Irit Arbel’s form 4 insider trades.
Insider Ownership Summary of Irit Arbel
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCLI | Brainstorm Cell Therapeutics Inc | 2019-12-12 | director |
| ONDR | Online Disruptive Technologies Inc | 2012-11-16 | Executive VP R&D |
| PLUR | Pluri Inc | 2003-12-30 | director & Chief Executive Officer |
Irit Arbel Latest Holdings Summary
Irit Arbel currently owns a total of 1 stock. Irit Arbel owns 10,389 shares of Brainstorm Cell Therapeutics Inc (BCLI) as of August 28, 2019, with a value of $12,259.
Latest Holdings of Irit Arbel
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BCLI | Brainstorm Cell Therapeutics Inc | 2019-08-28 | 10,389 | 1.18 | 12,259 |
Holding Weightings of Irit Arbel
Irit Arbel Form 4 Trading Tracker
According to the SEC Form 4 filings, Irit Arbel has made a total of 0 transactions in Brainstorm Cell Therapeutics Inc (BCLI) over the past 5 years. The most-recent trade in Brainstorm Cell Therapeutics Inc is the sale of 889 shares on August 28, 2019, which brought Irit Arbel around $48,928.
Insider Trading History of Irit Arbel
- 1
Irit Arbel Trading Performance
GuruFocus tracks the stock performance after each of Irit Arbel's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Irit Arbel is -6.57%. GuruFocus also compares Irit Arbel's trading performance to market benchmark return within the same time period. The performance of stocks bought by Irit Arbel within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Irit Arbel's insider trading performs compared to the benchmark.
Performance of Irit Arbel
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -3.29 | | | | | |
| Relative Return to S&P 500(%) | -5.22 | | | | | |
Irit Arbel Ownership Network
Ownership Network List of Irit Arbel
Ownership Network Relation of Irit Arbel
Irit Arbel Owned Company Details
What does Brainstorm Cell Therapeutics Inc do?
Who are the key executives at Brainstorm Cell Therapeutics Inc?
Irit Arbel is the director of Brainstorm Cell Therapeutics Inc. Other key executives at Brainstorm Cell Therapeutics Inc include Chief Executive Officer Chaim Lebovits , EVP & Head Global Clin Research Stacy Lindborg , and Chief Medical Officer Kirk Taylor .
Brainstorm Cell Therapeutics Inc (BCLI) Insider Trades Summary
Over the past 18 months, Irit Arbel made no insider transaction in Brainstorm Cell Therapeutics Inc (BCLI). Other recent insider transactions involving Brainstorm Cell Therapeutics Inc (BCLI) include a net purchase of 590,208 shares made by Chaim Lebovits , a net sale of 63,000 shares made by , and a net purchase of 11,500 shares made by Stacy Lindborg .
In summary, during the past 3 months, insiders sold 0 shares of Brainstorm Cell Therapeutics Inc (BCLI) in total and bought 23,836 shares, with a net purchase of 23,836 shares. During the past 18 months, 4,200 shares of Brainstorm Cell Therapeutics Inc (BCLI) were sold and 62,361 shares were bought by its insiders, resulting in a net purchase of 58,161 shares.
Brainstorm Cell Therapeutics Inc (BCLI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Brainstorm Cell Therapeutics Inc Insider Transactions
Irit Arbel Mailing Address
Above is the net worth, insider trading, and ownership report for Irit Arbel. You might contact Irit Arbel via mailing address: 6 Hadishon Streeet, Jerusalem, Israel 96596 L3 00000.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
